Navigation Links
Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St. John Wound Center
Date:6/18/2009

, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

These forward-looking statements include statements with respect to the Company's vision, mission, strategies, goals, beliefs, plans, objectives, expectations, anticipations, estimates, intentions, financial condition, results of operations, future performance and business of the company, including but not limited to, (i) potential additional funding by H.F. Lenfest, a member of our Board of Directors and a significant shareholder and PNC Bank, (ii) the trading of the Company's common stock on the Over-the-Counter Bulletin Board (iii) projections of revenues, costs of materials, income or loss, earnings or loss per share, capital expenditures, growth prospects, dividends, capital structure, other financial items and the effects of currency fluctuations, (iv) statements of our plans and objectives of the Company or its management or Board of Directors, including the introduction of new products, or estimates or predictions of actions of customers, suppliers, competitors or regulatory authorities, (v) statements of future economic performance, (vi) statements of assumptions and other statements about the Company or its business, (vii) statements made about the possible outcomes of litigation involving the Company, (viii) statements regarding the Company's ability to obtain financing to support its operations and other expenses, and (ix) statements preceded by, followed by or that include the words, "may," "could," "should," "looking forward," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan," or the negative of such terms or similar expressions. These forward-looking statements involve risks and uncertainties which are subject to change based on various important factors. Some of these risks and uncertainties, in who
'/>"/>

SOURCE Environmental Tectonics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
2. Landfill mining reduces environmental impact of growing waste
3. Landfill mining reduces environmental impact of growing waste
4. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
5. Environmental Tectonics Corporations BioMedical Division Announces New Contract
6. Environmental Tectonics Corporation Announces Sale of Monoplace Hyperbaric Chambers
7. NanoLogixs Hydrogen-From-Waste Technology at Welchs Foods Featured on Environmental Radio Program
8. Nanotechs health, environmental impacts worry scientists and the public
9. White Paper Details Environmental Health & Safety Compliance Strategies for Laboratories
10. Environmental Operating Solutions Completes Initial Tranche of $2.5 Million Institutional Financing
11. Environmental Power Announces Opening of New Corporate Headquarters in Tarrytown, NY

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...poricidin disinfectant solution and wipes are reli...ainst H1N1 and Influenza A., , ... Contec Inc, the leading manufacturer of clean ro... disinfectants have been deemed by the EPA as eff...Pandemic 2009 H1N1 influenza A virus (the swine fl...
(Date:11/23/2009)...re/--PearlTherapeuticsInc.,abiopharmaceuticalcompa...ronicrespiratorydiseases,todayannouncedtheappointm...osenhas25yearsofexperienceinthepharmaceuticalandbi...encesandALZACorporation.Hisappointmentincreasesthe...bringsawealthofproductdevelopment,commercializatio...
(Date:11/20/2009)... -- Veridiam (www.veridiam.com) won the prestigiou...t the 2009 Workplace Excellence Awards. The awards...Resources Management and recognize innovative and ...iam was one of nine winners, selected from more th...e recent awards ceremony. San Diego-based Veridiam...
(Date:11/20/2009)...e-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nas...Circuit Court of Appeals reversed a U.S. District ...o pursue all of its claims against The Lash Group,...rial. CTI filed a complaint against The Lash Grou...nt for CTI,s product TRISENOX, in 2007 seeking $22...
Breaking Biology Technology:Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2
...J., Jan. 31 Schering-Plough,Corporation (NYSE: S...dministration (FDA) has accepted the Peg-IFN (pegi...Application (sBLA) for review and has,granted Prio...atients with,Stage III melanoma. Schering-Plough s... of 2007., The Priority Review designation is int...
...l School Researchers Used Thermo Scientific Dharma...for Reproduction of the Virus that ...1 Thermo Fisher,Scientific Inc., the world leader...interference (RNAi) technology has enabled a groun...n, which identified human proteins,required for gr...
...Manufacture ARIUS, Product Candidate Trop-2 Signal...PRINCETON, N.J., Jan. 31 Laureate Pharma, Inc., a...rotein production company, today,announced that it...reement,with ARIUS Research, Inc., a biotechnology... next wave of antibody therapeutics to treat cance...
Other Biology Technology:FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 2FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 3FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 4FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 5FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 6Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 2Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 3Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 4Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 5Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody 2Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody 3
(Date:11/23/2009)... , This release is available in German . ,...instrument wouldn,t be a bad thing. It could help ...ble to measure. However, it must do so constructiv...ical measurement with more than just imagination, ...ysics have formulated a theory of spatial percepti...
(Date:11/23/2009)... , This release is available in German . ,...ace a long journey every year. Researchers at Prin... Institute for Ornithology in Radolfzell, Germany ...ant family of bats, the so-called "Vespertilionida...overed that the migration over short as well as lo...
(Date:11/22/2009)... , CINCINNATI -- Children exposed prenatally to t...articularly high risk for ADHD, according to resea... Center. , The study estimates that up to 35 per... 8 and 15 could be reduced by eliminating both of ...e into up to 800,000 children , "Tobacco and le...
Breaking Biology News(10 mins):Visual assistance for cosmic blind spots 2Visual assistance for cosmic blind spots 3Visual assistance for cosmic blind spots 4We're off then: The evolution of bat migration 2Exposure to lead, tobacco smoke raises risk of ADHD 2UC Riverside research on barley genome gets boost from 241 million USDA grant 9853 1UC Riverside research on barley genome gets boost from 241 million USDA grant 9853 2UC Riverside research on barley genome gets boost from 241 million USDA grant 9853 3UC Riverside research on barley genome gets boost from 241 million USDA grant 9853 4Hanson Technologies Inc Awarded Patent for its Advanced Food Pathogen Detection System 13956 1Hanson Technologies Inc Awarded Patent for its Advanced Food Pathogen Detection System 13956 2MRSA May Succumb to Honey 56675 1MRSA May Succumb to Honey 56675 2
...sociation of Biology Teachers (NABT) will recogniz...niversity of Minnesota, with the 2008 Evolution Ed... be held 15-18 October 2008 in Memphis, Tennessee.... by the American Institute of Biological Sciences ...y (BSCS). The award is presented in recognition o...
...ted as to the exact cell type that produces connec... the wound healing process. This knowledge gap is ...Fibrogenesis & Tissue Repair , a new open access j...rmally induced during tissue repair while elevated...rosis. In the paper Andrew Leask and his colleague...
... may hitch a ride on the wind, but a new study in ...l Press publication, confirms that they are anythi...rent Biology offered the first evidence that Silv...s, sailing on favorable winds to reach their south...ow, the research team that brought us that finding...
Other Biology News:Biologists, educators recognize excellence in evolution education 2Biologists, educators recognize excellence in evolution education 3Closing the gap: Journal launch brings together wound-healing knowledge 2Migratory moths may hitch their rides, but they're anything but drifters 2
...dominantly used for labeling proteins, the single ...ptides and nucleotides because they give better re...ed in the conjugation processes. 5-TAMRA is more o...roteins. 6-TAMRA is predominately used for labelin...
Chicken Anti-Lactate Dehydrogenase Antibody, Unconjugated from Immunology Consultants Laboratory, Inc.
Mouse Anti-LAP2 Monoclonal Antibody, Unconjugated, Clone 6E10 from Abcam
5% Alkali-Soluble Casein from Novagen
Biology Products: